RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MARALIXIBAT IN THE TREATMENT OF SUBJECTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (PFIC) ¿ MARCH-PFIC
- Registry ID
- MRX-502
- Source registry
- HEALTH_CANADA
- Status
- Closed
- Phase
- PHASE3
- Study type
- INTERVENTIONAL
- Sponsor
- MIRUM PHARMACEUTICALS, INC
- Start date
- 2020-12-29
- Completion date
- 2022-09-01
- Last update
- 2019-08-22
Conditions
- PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS
View on source registry